Pei-Pei Kung - Worldwide Research and Development, Pfizer Inc

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 88 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Legends for Figures 1-4, and Tables 1-2 from Effective Targeting of Triple-Negative Breast Cancer Cells by PF-4942847, a Novel Oral Inhibitor of Hsp 90

Pramod P. Mehta,Pamela Whalen,Sangita M. Baxi,Pei-Pei Kung,Shinji Yamazaki,Min-Jean Yin

openalex（2023）

Cited0Views0Bibtex

Development of Small Molecule Inhibitors of Natural Killer Group 2D Receptor (NKG2D)

Bioorganic & Medicinal Chemistry Letters (2023): 129492-129492

Cited1Views0WOSBibtex

Identification of Small-Molecule Protein-Protein Interaction Inhibitors for NKG2D

Aaron A. Thompson,Michael B. Harbut,Pei-Pei Kung,Nathan K. Karpowich, Jeffrey D. Branson,Joanna C. Grant, Deborah Hagan,Heather A. Pascual,Guoyun Bai,Reza Beheshti Zavareh,Heather R. Coate,Bernard C. Collins,Marjorie Cote,Christine F. Gelin,Kelly L. Damm-Ganamet,Hadi Gholami, Adam R. Huff, Luis Limon, Kevin J. Lum,Puiying A. Mak,Kohki M. Nakafuku,Edmund V. Price,Amy Y. Shih,Mandana Tootoonchi,Nadeem A. Vellore,Jocelyn Wang, Na Wei,Jeannie Ziff, Scott B. Berger,James P. Edwards, Agnes Gardet,Siquan Sun,Jennifer E. Towne,Jennifer D. Venable,Zhicai Shi,Hariharan Venkatesan,Marie-Laure Rives,Sujata Sharma,Brock T. Shireman,Samantha J. Allen

Proceedings of the National Academy of Sciencesno. 18 (2023)

Cited6Views0WOSBibtex

Supplementary Figure 4 from Effective Targeting of Triple-Negative Breast Cancer Cells by PF-4942847, a Novel Oral Inhibitor of Hsp 90

Pramod P. Mehta,Pamela Whalen,Sangita M. Baxi,Pei-Pei Kung,Shinji Yamazaki,Min-Jean Yin

openalex（2023）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn